DXCM Q4 2022 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$815M+16.8% YoY

Gross Profit

$541M66.4% margin

Operating Income

$125M15.4% margin

Net Income

$92M11.3% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

+5.9%

Cash Flow

Operating Cash Flow

$133M

Free Cash Flow

$69M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$5.4B

Total Liabilities

$3.3B

Stockholders' Equity

$2.1B

Cash & Equivalents

$642M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$815M	$698M	+16.8%
Gross Profit	$541M	$473M	+14.5%
Operating Income	$125M	$600,000	+20800.0%
Net Income	$92M	-$19M	+573.2%

Geographic Segments

UNITED STATES

$606M74%

Non-US

$209M26%